Advertisement
Screener

ProKidney Corp. (PROK) Cash and Restricted Cash

2.8 / 5 stars · 68/120 Roast Me

ProKidney Corp. Cash and Restricted Cash

ProKidney Corp. (PROK) had Cash and Restricted Cash of $74.87 million as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10

  • 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $74.87M.
  • 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $101.89M.
  • 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $108.54M.
  • 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $95.32M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed
2026-06-30$74.87M
10-Q · filed 2026-08-10
2026-03-31$101.89M
10-Q · filed 2026-05-15
2025-12-31$108.54M
10-Q · filed 2026-08-10
2025-09-30$95.32M
10-Q · filed 2025-11-10
2025-06-30$84.94M
10-Q · filed 2026-08-10
2025-03-31$97.81M
10-Q · filed 2026-05-15
2024-12-31$99.12M
10-Q · filed 2026-08-10
2024-09-30$108.09M
10-Q · filed 2025-11-10
2024-06-30$214.51M
10-Q · filed 2025-08-12
2024-03-31$84.39M
10-Q · filed 2025-05-12
2023-12-31$60.65M
10-K · filed 2026-03-18
2023-09-30$191.39M
10-Q · filed 2024-11-12
2023-06-30$243.55M
10-Q · filed 2024-08-09
2023-03-31$271.63M
10-Q · filed 2024-05-10
2022-12-31$490.25M
10-K · filed 2026-03-18
2022-09-30$506.33M
10-Q · filed 2023-11-14
2022-06-30$21.88M
10-Q · filed 2023-08-10
$107.55K
10-Q · filed 2022-08-12
2022-03-31$29.80M
10-Q · filed 2023-05-11
$51.89K
10-Q · filed 2022-05-16
2021-12-31$20.56M
10-K · filed 2025-03-17
$440.49K
10-Q · filed 2022-08-12
2021-09-30$4.09M
10-Q · filed 2022-11-14
2021-06-30$223.54K
10-Q · filed 2022-08-12
2021-03-31$0.00
10-Q · filed 2022-05-16
2021-02-24$0.00
10-Q · filed 2022-08-12
2020-12-31$4.58M
10-K · filed 2024-03-22
2019-12-31$15.23M
10-K · filed 2023-03-28